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Neutrophils exert both positive and negative influences on the host response to 
tuberculosis, but the mechanisms by which these differential effects are mediated 
are unknown. We studied the impact of live and dead neutrophils on the control of 
Mycobacterium tuberculosis using a whole blood bioluminescence-based assay, and 
assayed supernatant cytokine concentrations using Luminex™ technology and ELISA. 
CD15+ granulocyte depletion from blood prior to infection with M. tuberculosis-lux 
impaired control of mycobacteria by 96 h, with a greater effect than depletion of CD4+, 
CD8+, or CD14+ cells (p <  0.001). Augmentation of blood with viable granulocytes 
significantly improved control of mycobacteria by 96 h (p = 0.001), but augmentation 
with necrotic granulocytes had the opposite effect (p =  0.01). Both augmentations 
decreased supernatant concentrations of tumor necrosis factor and interleukin (IL)-12 
p40/p70, but necrotic granulocyte augmentation also increased concentrations of IL-10, 
G-CSF, GM-CSF, and CCL2. Necrotic neutrophil augmentation reduced phagocytosis of 
FITC-labeled M. bovis BCG by all phagocytes, whereas viable neutrophil augmentation 
specifically reduced early uptake by CD14+ cells. The immunosuppressive effect of 
dead neutrophils required necrotic debris rather than supernatant. We conclude that 
viable neutrophils enhance control of M. tuberculosis in blood, but necrotic neutrophils 
have the opposite effect—the latter associated with induction of IL-10, growth factors, 
and chemoattractants. Our findings suggest a mechanism by which necrotic neutrophils 
may exert detrimental effects on the host response in active tuberculosis.
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inTrODUcTiOn
Neutrophils interact with Mycobacterium tuberculosis (1, 2) and are important in the host immune 
response to this pathogen (3). However, their influence on the outcome of infection remains contro-
versial: while they may have a protective role in early infection (3), evidence exists for a detrimental 
effect in established tuberculosis disease (4, 5).
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Literature indicates that neutrophils have a profound impact 
on the development of innate and acquired immune responses 
(6, 7), but this has not been significantly studied in tuberculosis. 
In vivo data have revealed a lower percentage of interferon (IFN)-γ 
expressing CD4+ T cells in bronchoalveolar lavage samples from 
cavities, which are rich in neutrophils (8), but a causative relation-
ship has not been established.
Neutrophils are also frequently demonstrated to associate 
with tuberculosis immunopathology in animals (9, 10) and this 
appears to be specifically associated with necrosis (11). We have 
also previously observed that neutrophil antimycobacterial acti- 
vity is impaired during HIV-1 infection (12) and that this is asso-
ciated with rapid neutrophil necrosis. Others have also noted 
a neutrophilic response with significant necrosis in the tuber-
culous lesions of HIV-1 co-infected persons, in association with 
impaired tumor necrosis factor (TNF) staining (13). Animal 
models link neutrophil necrosis with pathogen virulence and 
host susceptibility (14), or link overall necrosis of granulomas 
with bacillary burden (15), suggesting that this pattern of cell 
death may correlate with severity of disease. More recently, it has 
been demonstrated via immunohistochemistry that neutrophil 
markers in human tuberculous granulomas associate with areas 
of necrosis and with interleukin (IL)-10, while a pronounced neu-
trophilic necrosis response correlates with enhanced numbers of 
M. tuberculosis organisms (16).
We therefore investigated the influence of viable and necrotic 
neutrophils on the immune response to tuberculosis. We first 
examined the cytokine and chemokine profile of supernatants 
aspirated from whole blood which had been depleted of neutro-
phils or various other cell types before incubation with M. tub er­
culosis. We also examined the impact of augmenting blood with 
additional autologous neutrophils [as they are recruited in large 
numbers to sites of tuberculosis infection (1)] on both the control 
of infection and the cytokine response, using an ex vivo whole 
blood model (17, 18). We then investigated whether the effect of 
necrotic neutrophils contrasted with viable neutrophils in modu-
lating the control of and response to infection. These experiments 
modeled a situation of neutrophilia with rapid cell death, as may 
be seen in necrotic granulomata, in tuberculosis-HIV co-infection 
or in severe tuberculosis disease.
MaTerials anD MeThODs
Patients and recruitment
Participants for depletion experiments were recruited among 
people who had recently tested negative for HIV in Khayelitsha, 
South Africa, either at the Ubuntu Site B clinic or the Khayelitsha 
Youth Centre. Augmentation and phagocytosis experiments were 
performed using blood from healthy lab donors.
ethics
The studies were approved by the University of Cape Town 
Research Ethics Committee (HREC 545/2010) in South Africa 
and NHS Research Ethics Committee (REC 08-H0720-46) in 
the UK and performed in accordance with the Declaration of 
Helsinki. Participants provided written informed consent.
Organisms and labeling
The development of luminescent mycobacteria, including plas-
mid construction and electroporation, has been described prev-
iously (19). 1.5 ml vials of M. tuberculosis-lux stored at −80°C 
were thawed and added to 15 ml 7H9 (Becton Dickinson)/ADC 
(Becton Dickinson) growth medium containing 0.05% Tween 
80 (Sigma) and 1 mcl/ml hygromycin B (Roche diagnostics). 
Organisms were cultured to mid-log phase (72 h) before use. 
Luminescence was measured as previously described (2). M. bovis 
BCG-lux organisms were processed similarly but cultured in 
20 ml 7H9/ADC. Non-luminescent M. bovis BCG were cultured 
to mid-log phase in 7H9/ADC (monitored by optical density) and 
labeled with FITC when required for experiments, as previously 
described (2).
cell Depletion and neutrophil isolation
For comparative depletion experiments, heparinized blood was 
divided into aliquots and incubated with Miltenyi MicroBeads at 
2–8°C. Volumes and incubation times were optimized for each 
antigen and achieved approximately 90% depletion of the target 
cell [anti-CD4: 100 mcl/ml, 30 min; anti-CD8: 50 mcl/ml, 15 min; 
anti-CD14: 100 mcl/ml, 30 min; anti-CD15: 50 mcl/ml, 15 min; 
Basic (unconjugated) MicroBeads used for controls: 50  mcl/ml, 
15–30 min; see Figure S1 in Supplementary Material]. Blood was 
diluted 1:1 with RPMI-1640 and passed through Miltenyi Biotec 
LS columns supported in magnets (MidiMACS Separation Unit, 
Miltenyi Biotec); columns had been pre-“primed” with 3 ml MACS 
buffer [0.5% bovine serum albumin (Sigma) and 2  mM EDTA 
(Sigma)], all as previously described (2). Depleted blood was col-
lected in Universal containers. Granulocyte isolation using discon-
tinuous Percoll gradient was performed as previously described 
(2). Neutrophils were rendered necrotic (when required) via heat 
shock at 60°C for approximately 20 min, until all cells were trypan 
blue (Sigma) positive by microscopy, and then allowed to cool.
Whole Blood lux assay
This was performed as previously described in detail (17, 18). 
Briefly, for comparative depletion experiments, approximately 
5 × 105 cfu mid-log phase M. tuberculosis-lux in 100 mcl PBS was 
added to triplicate samples of 900 mcl specific cell-depleted or 
undepleted (Basic MicroBead-treated) blood, already diluted 1:1 
with RPMI as described above. For augmentation experiments, 
the same inoculum was added to triplicate samples of 450 mcl 
venous blood pre-mixed 1:1 with either RPMI-1640, viable 
neutrophils in RPMI-1640 or necrotic neutrophils in RPMI-
1640. For each donor, inocula were identical between different 
depletion/augmentation conditions. Samples were incubated at 
37°C on a rocking platform for 96 h; mycobacterial luminescence 
was measured after removal of supernatants, cell lysis with 10 ml 
water, centrifugation at 2,000 × g for 10 min and resuspension 
in 1 ml PBS. Supernatants did not contain significant quantities 
of mycobacteria despite effective release from cells during lysis 
(Figure S2 in Supplementary Material). Uninfected samples 
served as controls for cytokine analysis. For comparison of the 
effects of necrotic neutrophil debris versus supernatants, sam-
ples were processed identically except that all Percoll-isolated 
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neutrophils were heat-shocked and the necrotic neutrophils 
were then centrifuged at 1,200 × g for 6 min. Supernatants were 
removed and the necrotic cell pellet resuspended; 450  mcl ali-
quots of reserved whole blood were then mixed 1:1 with necrotic 
neutrophils, necrotic neutrophil supernatant, or RPMI-1640 
alone in duplicate (plus one uninfected sample per donor and 
condition). The infecting organism in these experiments was 
M. bovis BCG, added at the same multiplicity of infection.
Phagocytosis assay
Samples were prepared as for the lux assay, with the addition of 
viable, necrotic, or no autologous neutrophils to venous blood, 
in duplicate per experimental condition. Samples were infected 
with 100  mcl FITC-labeled BCG organisms diluted according 
to optical density to approximately 2 ×  106  CFU/ml. For each 
donor, inocula were identical between different augmentation 
conditions. Samples were mixed and incubated at 37°C for 1 h.
Subsequently, two 200 mcl aliquots were taken from the sam-
ples, to which 10 mcl anti-CD14-PE (Becton Dickinson) and 1 mcl 
BD Horizon™ Fixable Viability Stain 450 (Becton Dickinson) 
were added. After 20 min, red blood cells were lysed via 15-min 
incubation with 2 ml 1× BD Pharm Lyse™ (Becton Dickinson). 
Samples were then centrifuged at 600 × g for 5 min, resuspended 
in 1 ml Stain Buffer (BD Pharmingen™) with 12.5 mcl filtered 
trypan blue (Sigma), centrifuged again, fixed in 500 mcl Cytofix 
(Becton Dickinson) for 15 min and finally resuspended in 1 ml 
Stain Buffer. Samples were processed on a BD Fortessa flow 
cytometer and data analyzed with FlowJo software (Treestar). 
Figure S3 in Supplementary Material details the gating strategy 
employed; results are presented as mean of duplicate results per 
donor/condition.
TnF and il-10 elisa
These were performed on supernatants according to manu-
facturer’s instructions (Peprotech, Rocky Hill, NJ, USA). Final 
dilutions were fivefold; results are presented as mean of duplicate 
samples per patient/condition. Undetectable readings were 
assigned an arbitrary value of 1 pg/ml (below the limit of detec-
tion of the assay).
Quantiferon-TB gold™ in-Tube  
iFn γ release assay
This was performed according to manufacturer’s instructions.
luminex™
Supernatants from 96-h blood samples infected with M. tuberculosis- 
lux were pooled across triplicates per participant/condition, filtered 
twice through 0.22 µm filter plates (Merck Millipore, Billerica, 
MA, USA) with centrifugation at 3,000 ×  g and diluted appr-
opriately according to preliminary results: final dilutions were 
either 4-fold or 10-fold depending on the experiment. The Invi- 
trogen 30-plex kit (Invitrogen, Carlsbad, CA, USA) was used 
according to manufacturer’s instructions, but we used a lower vol-
ume of beads: either 12.5 or 8.4 mcl. Plates were read on a calibrated 
Luminex 200™ reader and results calculated by the Luminex 
200™ software.
statistics
Parametric data were analyzed using Student’s t-tests when com-
paring two groups (paired when appropriate) or one-way ANOVA 
for comparing three or more groups with post  hoc correction. 
Non-parametric data were analyzed using Mann–Whitney U-tests 
or Wilcoxon signed rank tests for two groups and Kruskal–Wallis 
or Friedman testing with post hoc Dunn’s correction for three or 
more groups.
All statistical analyses were performed using SPSS Version 
18.0 (SPSS Inc., Chicago, IL, USA) or GraphPad Prism version 
4.0 or later. All reported p-values are two-sided; p <  0.05 was 
inferred as significant.
Principal component analysis (Pca)
Principal component analysis and associated three-dimensional 
plots were generated using Qlucore™ Omics Explorer v2.3 soft-
ware. Multi-group comparison was used to identify Luminex™-
measured cytokines or chemokines that were differentially 
abundant bet ween the supernatants of three conditions (blood 
augmented with viable neutrophils, necrotic neutrophils, or med-
ium only). A p-value of maximum 0.05 and q-value of maximum 
0.1 were used as thresholds. Individual points in the plots repre-
sented one donor in one augmentation condition and their position 
in the plot was determined by the combined effects of all param-
eters measured for the sample that significantly contributed to the 
overall between-group difference. The distance between sample 
points represents Euclidean distance and was calculated using all 
parameters that significantly contribute to the overall between-
group difference. Component vectors are displayed, along with a 
percentage figure signifying the proportion of the variability in 
the data that each component accounts for.
resUlTs
Depletion of neutrophils From Whole 
Blood impairs Mycobacterial control More 
Than Depletion of Other cell Types
Aliquots of blood from 20 healthy, HIV-uninfected persons 
(10 with positive results from Quantiferon-TB Gold In-Tube 
IFN-γ release assay) were depleted of CD4+, CD8+, CD14+, or 
CD15+ cells via Miltenyi MACS magnetic beads or were incu-
bated with non-conjugated beads as controls. This blood was then 
infected with M. tuberculosis-lux and incubated in rocking tubes 
for 96 h, as per the previously described whole blood lux assay 
(17). The mean (SD) neutrophil count in mock-depleted blood 
[treated with Basic (unconjugated) Microbeads, diluted 1:1 with 
RPMI-1640] was 1.42 ± 0.53 × 109/l and in CD15-depleted blood 
was 0.20 ± 0.17 × 109/l. Figure 1 details the impact of cell deple-
tion on the 96-h luminescence of M. tuberculosis­lux. CD15+ cell 
(granulocyte) depletion had a greater effect than depletion of any 
other cell type on mycobacterial luminescence (a surrogate of 
mycobacterial metabolism and/or number) at 96 h (mean RLU 
per 100  mcl 88,686 ±  44,734 in mock-depleted blood versus 
146,681 ±  72,663 in CD15-depleted blood, 102,262 ±  52,568 
in CD4-depleted blood, 97075 ± 38993 in CD8-depleted blood 
and 111,338 ±  52,879 in CD14-depleted blood; p <  0.001 for 
FigUre 1 | Impact of cell depletions on control of mycobacterial 
luminescence in whole blood. Blood was taken from 20 donors. 450 mcl  
of blood depleted of CD4+, CD8+, CD14+, CD15+ or no cells (in triplicate 
per donor per condition), diluted 1:1 with RPMI-1640, was infected with 
approximately 5 × 105 CFU Mycobacterium tuberculosis-lux in 100 mcl PBS. 
Samples were incubated on a rocking plate (20 rpm) at 37°C for 96 h before 
removal of supernatants, lysis of red blood cells with water, resuspension in 
1 ml PBS and measurement of mycobacterial luminescence on at least two 
100 mcl aliquots. Results presented are the mean of all measurements 
across triplicate samples for the relevant condition. ***p < 0.001  
(one-way ANOVA).
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there was significantly (p <  0.05) reduced CCL2 concentration 
versus undepleted blood [median (IQR) concentration 1,420 
(807–1,684) ng/ml in CD15-depleted blood supernatants versus 
1,903 (1,084–3,386) ng/ml in mock-depleted blood supernatants].
addition of Viable neutrophils to human 
Whole Blood improves Mycobacterial 
control at 96 h, While addition of necrotic 
neutrophils has the Opposite effect
We proceeded to investigate the effect of augmenting blood with 
either viable or necrotic neutrophils on mycobacterial restric-
tion and cytokine release. Neutrophils from nine donors were 
isolated by discontinuous Percoll gradient and divided into two 
equal aliquots; one half was then heat-shocked at 60°C (and sub-
sequently cooled) and either viable neutrophils, necrotic neutro-
phils, or medium only were added to aliquots of the same donor’s 
blood (kept aside at the time of venepuncture, for a maximum 
of 2 h). The whole blood lux assay was conducted as previously 
described (17, 18).
Overall neutrophil purity assessed by Coulter counting was 
97.79 ± 1.16%. The non-augmented mean ± SD neutrophil count 
was 2.10 ± 0.75 × 109/l versus 9.00 ± 3.30 × 109/l in those samples 
augmented with viable neutrophils (p <  0.0001). Lymphocyte 
counts were not significantly different: 1.18 ± 0.53 × 109/l in non-
augmented versus 1.30 ± 0.59 × 109/l (p = 0.09) in neutrophil-
augmented blood. Luminescence readings at 96 h post-infection 
(performed in at least duplicate per donor per condition) were 
9,379  ±  4,888 RLU per 100  mcl for non-augmented blood. 
Luminescence was significantly decreased in samples augme-
nted with viable neutrophils (2,766 ±  1,672 RLU per 100  mcl, 
p < 0.001), and 96-h luminescence correlated inversely with the 
number of neutrophils using all data from non-augmented or 
viable-augmented samples (p < 0.001). Conversely, augmentation 
with necrotic neutrophils increased mean luminescence at 96 h 
post-infection to 11,722 ±  6,132 RLU per 100  mcl (p =  0.013 
versus no augmentation, Figure 3A).
addition of Viable or necrotic neutrophils 
to human Whole Blood results in a 
significant alteration of cytokine and 
chemokine response
Supernatants from these experiments were assayed by Luminex™ 
30-plex technology. In total, 26 cytokines or chemokines were 
detectable with a median value greater than the lower limit of detec-
tion. To identify differences in inflammatory profile between the 
three conditions (non-augmented, viable neutrophil-augmented, 
or necrotic neutrophil-augmented) we employed Qlucore™ 
Omics Explorer v2.3 to perform PCA. Initial exploration of data 
suggested that neutrophil manipulation by itself had a significant 
effect on cytokine and chemokine responses; subtracting unin-
fected control values, therefore, removes some of the biological 
effect and we present analysis on raw data.
Principal component analysis showed clear differences in 
inflammatory profiles between the non-augmented, viable neutro-
phil-augmented, and necrotic neutrophil-augmented conditions 
CD15-depleted versus any other condition). We note that by 
pairwise comparison versus undepleted blood, both CD4 deple-
tion (p = 0.016) and CD14 depletion (p = 0.004) also impaired 
control of mycobacterial luminescence, although the effects were 
more modest than with CD15 depletion.
cD15+ cell Depletion has relatively little 
effect on the cytokine and chemokine 
concentrations in supernatants of  
M. tuberculosis-infected Blood
Luminex™ analyses of cytokines and chemokines in the superna-
tants from depletion experiments (see above) are summarized in 
Figure 2 and Table 1, which indicate those analytes significantly 
affected by cell depletion after correction for multiple pairwise 
comparisons by the Bonferroni methodology. Uninfected control 
samples showed low or undetectable levels of most analytes, although 
when they were detected there was evidence that cell depletion by 
itself had a significant effect on cytokine and chemokine responses; 
subtracting baseline values from uninfected controls thus removes 
some of the biological effect of the depletion and we, therefore, 
present analysis on raw data.
Depletion of CD8+ cells had no effect on the cytokine profile of 
96-h blood supernatants, while the effect of depletion of CD4+ cells 
significantly reduced supernatant concentrations of 16 predomi-
nantly Th1-associated cytokines, innate inflammatory cytokines, 
and chemokines. CD14+ cell depletion markedly reduced the 
concentration of 16 similar molecules. CD15+ cell depletion had 
less effect on the supernatant analyte profile than CD4+ or CD14+ 
cell depletion, but after correction for multiple comparisons 
FigUre 2 | Continued
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(Figure 3B; Table S1 in Supplementary Material details p- and 
q-values). Figure 4 presents analyte concentrations and displays 
results from one-way ANOVA for each cytokine or chemokine 
found to contribute to the separation of groups in PCA. Maximal 
cytokine responses were seen in the non-augmented blood. 
Viable neutrophil augmentation was broadly anti-inflammatory, 
FigUre 2 | Impact of cell depletions on supernatant cytokines and chemokines from Mycobacterium tuberculosis-infected blood. (a–r). Supernatants from the 
experiments presented in Figure 1 (blood from 20 donors depleted of CD4+, CD8+, CD14+, CD15+ or no cells and infected with M. tuberculosis-lux for 96 h) were 
aspirated and stored at −80°C until analysis by Luminex™ technology. Box and whisker plots represent median, interquartile range, minimum and maximum values 
for each analyte. Abbreviations: VEGF, vascular endothelial growth factor; TNF, tumor necrosis factor; IFN, interferon; IL, interleukin; IL-2R, interleukin-2 receptor; 
IL-1RA, interleukin-1 receptor antagonist; FGFb, fibroblast growth factor basic; EGF, epidermal growth factor; CXCL, C-X-C motif ligand; CCL, C-C chemokine 
ligand; CD, cluster of differentiation.
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p =  0.027; Figure  5A). However, among BCG-FITC+ events, 
viable—but not necrotic—neutrophils reduced relative phagocy-
tosis of BCG by CD14+ cells after 1 h of incubation (mean ± SD 
percentage of BCG-FITC+ events associating with CD14+ 
monocytes: in non-augmented blood 3.62  ±  0.98, in viable 
neutrophil-augmented blood 1.24 ± 0.38, p < 0.001 versus non-
augmented, in necrotic neutrophil-augmented blood 2.89 ± 075, 
p < 0.01 versus viable-augmented; Figure 5B). Correspondingly, 
the percentage of BCG-FITC+ associating with neutrophils 
significantly increased with the addition of viable neutrophils 
(mean ± SD percentage: in non-augmented blood 69.72 ± 8.90, 
in viable neutrophil-augmented blood 82.95 ±  3.74, p <  0.001 
versus non-augmented, in necrotic neutrophil-augmented blood 
74.09 ± 7.72, p < 0.01 versus viable-augmented; Figure 5C).
The immunosuppressive effect of necrotic 
neutrophils requires Direct contact With 
cellular Debris
We hypothesized that some of the immunosuppressive effect of 
necrotic neutrophils might be mediated via a soluble factor, as has 
previously been described with other organisms (20). We there-
fore added necrotic neutrophils, their supernatant, or medium 
reducing supernatant concentrations of IL-1β, TNF, IL-12p40/p70, 
CCL3, CCL5, interleukin-2 receptor (IL-2R), and fibroblast gro-
wth factor basic (FGFb); only hepatocyte growth factor (HGF) 
was increased. The addition of necrotic neutrophils to blood was 
also associated with lower supernatant concentrations of IL-1β, 
TNF, IL-12p40/p70, and FGFb, but simultaneously provoked an 
increase in IL-10, G-CSF, GM-CSF, and CCL2.
addition of necrotic neutrophils to Whole 
Blood reduces Phagocytosis Overall, 
While addition of Viable neutrophils 
reduces Phagocytosis of Mycobacteria 
specifically by cD14+ cells
To investigate the mechanism by which neutrophils elicited an 
anti-inflammatory response to mycobacterial infection, we meas-
ured phagocytosis of FITC-labeled M. bovis BCG by CD14+ 
cells (shown earlier to be the major source of cytokines and 
chemokines in the whole blood model, Figure 2).
The addition of necrotic neutrophils reduced the overall 
percentage of events associating with BCG-FITC+ (mean ± SD 
percentage 4.51 ± 1.15 versus 6.82 ± 2.21 with no augmentation, 
p = 0.047, and 6.11 ± 0.88 with viable neutrophil augmentation, 
TaBle 1 | Summary of impact of cell depletions on supernatant cytokines and 
chemokines from Mycobacterium tuberculosis-infected blood.
Depleted cell
cD4 cD8 cD14 cD15
VEGF ↓ ↓
TNF ↓ ↓
IFN-α ↓ ↓
IL-8 ↓ ↓
IL-7 ↓ ↓
IL-6 ↓ ↓
IL-2R ↓ ↓
IL-1RA ↓ ↓
IL-1β ↓ ↓
IL-12p40p70 ↓ ↓
FGFb ↓ ↓
Eotaxin
EQF ↓
CXCL10 ↓ ↓
CCL5 ↓
CCL4 ↓ ↓
CCL3 ↓ ↓
CCL2 ↓ ↓ ↓
Down arrows indicate those analytes which remain significantly decreased in the 
depleted condition compared to mock-depleted (p < 0.05, Wilcoxon matched pairs) 
after adjustment for multiple comparisons via the Bonferroni methodology.
VEGF, vascular endothelial growth factor; TNF, tumor necrosis factor; IFN, interferon; 
IL, interleukin; IL-2R, interleukin-2 receptor; IL-1RA, interleukin-1 receptor antagonist; 
FGFb, fibroblast growth factor basic; EGF, epidermal growth factor; CXCL, C-X-C motif 
ligand; CCL, C-C chemokine ligand; CD, cluster of differentiation.
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alone to aliquots of blood in 17 donors before incubation with 
M. bovis BCG for 96  h. Supernatants were then aspirated and 
assayed for TNF and IL-10 using ELISA.
As shown in Figures 5D,E, the addition of necrotic neut ro phils 
to blood resulted in reduced TNF and increased IL-10 similar to 
previous results (mean ± SD TNF concentration in non-augmented 
blood 1,069 ±  1,351  pg/ml, in necrotic neutrophil-augmented 
blood 613 ± 814 pg/ml, p < 0.05; mean ± SD IL-10 concentration 
in non-augmented blood 899 ± 478 pg/ml, in necrotic neutrophil- 
augmented blood 1,236 ± 870 pg/ml, p < 0.05). However, addi-
tion of the supernatants of necrotic neutrophils alone did not 
have a significant impact on cytokine levels, albeit trends were 
evident (mean ±  SD TNF concentration 713 ±  680  pg/ml, 
mean ± SD IL-10 concentration 1,040 ± 582 pg/ml).
DiscUssiOn
Both viable (1) and necrotic (16) neutrophils are found in large 
numbers at the sites of human tuberculosis disease, where they 
will interact with mycobacteria and other cells of the immune 
system. We therefore investigated the impact of these cells on the 
control of mycobacteria and associated immune responses in a 
human blood model.
We have previously reported that neutrophils are crucial for 
the control of mycobacterial growth in human blood (21), and 
we here confirm and extend that finding via both depletion and 
augmentation experiments. Depletion of CD15+ granulocytes 
from blood has a greater adverse effect on mycobacterial control 
in whole blood than depletion of CD4+, CD8+, or CD14+ cells. 
It was interesting to note that depletion of CD15+ cells has 
relatively little effect on the cytokine and chemokine profile of 
M. tuberculosis-infected blood, suggesting that the mechanism 
of restriction of mycobacterial growth by neutrophils is likely 
to be directly mycobactericidal (or perhaps relates to cytokines 
and chemokines not measured here). Depletion of CD14+ cells 
and CD4+ cells did significantly impair the release of cytokines and 
chemokines, but this apparently had less effect on bacillary 
metabolism. These results raise the possibility that neutrophils, as 
the dominant cell type in human peripheral blood, are of impor-
tance for preventing hematogenous dissemination of bacilli. We 
note that, especially in areas of high endemicity, tuberculosis is 
noted not uncommonly as a cause of neutropenic sepsis (22, 23), 
while neutropenia is also associated with disseminated non-
tuberculous mycobacterial infection and poor outcome from 
such infection (24).
Consistent with these findings, the addition of viable neutro-
phils to blood significantly improved control of mycobacteria. 
However, this intervention suppressed inflammatory responses 
and was associated with reduced phagocytosis of mycobacteria 
by CD14+ cells (organisms were instead taken up by neutrophils, 
which is likely to be simply a consequence of the relative numbers 
of each cell type). We propose that early intracellular killing by 
neutrophils results in less subsequent activation of innate and 
acquired immune responses. There may also be a contribution 
from the immunosuppressive effects of programmed apoptosis, 
although we have not specifically assessed this. It is interesting to 
note that in vivo data demonstrate poorer local IFN-γ response 
from CD4+ T cells in bronchoalveolar lavage samples from cavi-
ties, where neutrophils dominate (8). We note that the neutrophil 
augmentation experiments impacted on cytokine responses far 
more than neutrophil depletion experiments, which might reflect 
the greater absolute change in cell count of this manipulation.
We have observed (12) and others have also reported (13, 25) 
accelerated neutrophil necrosis in HIV-infected persons, and 
have hypothesized that this may be important in the aberrant host 
response to pathogens. Animal models also link neutrophil influx 
and associated necrosis to poor outcome (11), while neutrophilia 
in active tuberculosis correlates with poor outcome (4). We show 
here that the addition of necrotic neutrophils to blood, even in 
healthy donors, enhances the metabolism of M. tuberculosis while 
supressing protective cytokine responses believed to contribute 
to protection and increasing the release of immunosuppressive 
IL-10. We have previously demonstrated that the addition of 
necrotic neutrophils directly to mycobacteria does not restrict 
their growth by 1 or 24 h (2), and thus the effects seen here in the 
whole blood model are likely to be mediated via an impact on 
the responses of other immune cells to M. tuberculosis infection.
Simultaneously, growth factors (G-CSF and GM-CSF) and the 
chemokine CCL2 are also increased. Although favorable roles 
have been suggested for some of these molecules in mycobacte-
rial infection, for example GM-CSF (26), their predominant role 
at sites of inflammation is to attract more cells—including more 
neutrophils.
The addition of necrotic neutrophils resulted in a global decr ease 
in phagocytosis, with less cell events associating with organisms 
than with either viable neutrophil or no augmentation. However, 
FigUre 3 | Impact of viable and necrotic neutrophil augmentation on control of mycobacterial luminescence by whole blood and on supernatant cytokines and 
chemokines from Mycobacterium tuberculosis-infected blood. (a) 100,000 RLU of M. tuberculosis-lux in 100 mcl PBS was inoculated into samples of 450 mcl 
whole blood plus either 450 mcl Percoll-isolated autologous neutrophils in RPMI-1640 heat-shocked at 60°C for 20 min and allowed to cool (“+Necrotic Neut”), 
450 mcl RPMI-1640 only (“+Nil”), or 450 mcl room temperature Percoll-isolated autologous neutrophils in RPMI-1640 (“+Viable Neut”). After 96-h incubation, red 
blood cells were lysed and luminescence was measured on at least two aliquots of 100 mcl. Results are shown from nine independent donors. (B) Three-
dimensional principal component analysis (PCA) plot generated using cytokine/chemokines that significantly contribute to differentiation between supernatants of 
augmentation conditions (calculated using multi-group comparison; purple = non-augmented, blue = necrotic neutrophil-augmented, yellow = viable neutrophil-
augmented). PCA is a technique to reduce the dimensionality of complex datasets by transforming the data to a coordinate system. The first three coordinates 
(principal components) are represented as a 3D plot. The first principal component accounts for as much variability as possible within the data, and each 
succeeding component accounts for the next highest proportion of the variability possible, but under the constraint that it is not correlated with preceding 
components. This allows visualization of the differences between patient samples and analytes within complex datasets. Individual points represent one donor  
in one augmentation condition and their position in the plot is determined by the combined effects of all parameters measured for the sample that significantly 
contribute to the overall between-group difference. Component vectors for the three main components are displayed, along with a percentage figure signifying  
the proportion of the variability in the data that each component accounts for. Analysis is presented using raw values from infected supernatants.
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there was not a specific effect on CD14+ cells. We therefore sug-
gest that necrotic neutrophils reduce phagocytosis both by viable 
neutrophils (hence reducing early killing) and by mononuclear 
phagocytes (impairing protective cytokine responses), presumably 
because phagocytes internalize neutrophil debris instead. Indeed, 
the immunosuppressive process (reduction in TNF production 
and increase in IL-10), at least with BCG, required direct contact 
with cellular debris. We had hypothesized a directly suppres-
sive role of neutrophil contents such as HNP 1–3, as previously 
described in other systems (20), but this does not appear to be 
a dominant mechanism in our BCG experiments (unfortunately 
we were unable to perform these same experiments with M. tuber­
culosis). Recent data have suggested an additional mechanism 
wherein necrotic neutrophils interfere with the phagosomal pro-
cessing of M. tuberculosis by macrophages and thereby subsequent 
control of the mycobacteria (27).
We thus propose that in the context of active tuberculosis 
with necrotic neutrophilic inflammation, as may be seen severe 
tuberculosis or certain pathological states, there will be impaired 
mycobacterial control, reduction of protective but enhancement 
of immunosuppressive cytokine responses, and an ongoing 
influx of neutrophils to perpetuate this pathological cycle. 
This correlates with post mortem descriptions of tuberculous 
granulomas in HIV-1 co-infected patients which demonstrate 
extensive necrosis, marked neutrophil infiltration, and reduced 
TNF staining (13). Similarly, recent findings suggest that the 
CD15 neutrophil marker co-localizes with areas of necrosis and 
with IL-10 in tuberculous granulomas, and that the extent of this 
response correlates with M. tuberculosis burden (16). The results 
presented here suggest that the necrotic neutrophils may directly 
drive the IL-10 response and increased bacillary numbers rather 
than being simply epiphenomena.
This work has limitations, in addition to those already 
discussed above. Human hosts encounter M. tuberculosis at 
mucosal membranes rather than blood, although blood does 
represent a useful medium for study since it contains both innate 
FigUre 4 | Detailed impact of viable and necrotic neutrophil augmentation on supernatant cytokines and chemokines from Mycobacterium tuberculosis- 
infected blood. (a–O) Cytokines and chemokines were measured in 96-h supernatants of M. tuberculosis-infected blood which had been augmented with  
necrotic autologous neutrophils (“+Necrotic”), with medium only (“+Nil”), or with viable autologous neutrophils (“+Viable”). Bars represent mean ± SD for each 
analyte found to be significant in principal component analysis. Presented are p-values from one-way ANOVA with Bonferroni correction comparing both augmented 
conditions with the medium-only control: *p < 0.05, **p < 0.01, ***p < 0.001. Data are from nine separate donors in four independent experiments. Abbreviations: 
IL, interleukin; TNF, tumor necrosis factor; FGFb, fibroblast growth factor basic; G-CSF, granulocyte-colony stimulating factor; GM-CSF, granulocyte macrophage-
colony stimulating factor; CCL, C-C chemokine ligand; CXCL, C-X-C motif ligand; IL-2R, interleukin-2 receptor; HGF, hepatocyte growth factor.
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and acquired immune system components. Heat shock is not the 
mechanism by which neutrophils die in vivo, but it does reliably 
induce necrosis within a short time: this method thus intended 
that autologous aliquots of viable neutrophils and whole blood 
should not experience significant cell death or other changes in 
the interim while necrotic cells were prepared. Depletion was not 
absolute for the target cells, but we felt that an approximately 90% 
reduction in cell count was likely to be biologically significant. 
As mentioned above, certain experiments were performed 
with M. bovis BCG rather than M. tuberculosis for reasons of 
biosecurity, and although we have previously seen similar results 
between these organisms in terms of neutrophil phagocytosis (2) 
and neutrophil control of mycobacterial luminescence (21), care 
should still be taken in extrapolating between organisms.
In summary, our data support the importance of neutrophils in 
the host response to tuberculosis both via a direct antimycobacterial 
FigUre 5 | Effect of viable and necrotic neutrophil augmentation on phagocytosis of FITC-labeled M. bovis BCG, and differential effect of necrotic neutrophil 
augmentation versus supernatant of necrotic neutrophils on cytokine release in blood. (a–c) Blood from six donors (four independent experiments) was augmented 
with viable neutrophils, necrotic neutrophils, or medium alone, infected with 2 × 105 CFU FITC-labeled M. bovis BCG and incubated for 1 h at 37°C. 2 × 100 mcl 
aliquots were taken from each sample, incubated with CD14-PE and Viability Dye for 20 min, red blood cells were lysed, trypan blue was added to quench 
extracellular fluorescence and samples fixed in 2% paraformaldehyde before acquisition on a BD Fortessa flow cytometer. Results are presented as the percentage 
of BCG-FITC+ events (a), the percentage of BCG-FITC+ events associated with CD14+ cells (B), and the percentage of BCG-FITC+ events associated with 
neutrophils [as defined by forward and side scatter among CD14 negative events (c)]. (D,e) Blood from 17 donors (4 independent experiments) was augmented 
with necrotic neutrophils, the supernatant of necrotic neutrophils, or medium alone, infected with 2 × 105 CFU M. bovis BCG and incubated for 96 h at 37°C. 
Samples were centrifuged and supernatants stored at −80°C until analysis by ELISA for tumor necrosis factor (TNF) (a) or interleukin-10 (B). Lines represent means, 
*p < 0.05 **p < 0.01, ***p < 0.001.
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activity and via an effect on the development of acquired immune 
responses. In particular, necrotic neutrophils impair mycobacte-
rial control, reduce protective cytokine responses, and drive IL-10 
and growth factor release: this pathological cycle may contribute 
to the negative association between neutrophilia and host prog-
nosis (4).
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